Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
BRNS Barinthus Biotherapeutics
- 0.913
- +0.093+11.28%
Close Dec 13 16:00 ET
36.71MMarket Cap-0.61P/E (TTM)
0.972High0.820Low20.49KVolume0.972Open0.820Pre Close18.10KTurnover0.07%Turnover RatioLossP/E (Static)40.23MShares4.15952wk High0.23P/B25.71MFloat Cap0.80152wk Low--Dividend TTM28.17MShs Float17.990Historical High--Div YieldTTM18.51%Amplitude0.801Historical Low0.883Avg Price1Lot Size
About Barinthus Biotherapeutics Company
Barinthus Biotherapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer. It also focuses on the pipeline of both clinical and preclinical stage therapeutic, and prophylactic programs. The company was founded by Adrian Hill and Dame Sarah Gilbert in March 2021 and is headquartered in Didcot, the United Kingdom.
Company Profile
SymbolBRNS
Company NameBarinthus Biotherapeutics
Listing DateApr 30, 2021
Issue Price17.00
Founded2021
CEOMr. William J. Enright
MarketNASDAQ
Employees98
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressZeus Building,Rutherford Avenue,Unit 6-10, Harwell
CityDidcot
ProvinceOxfordshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeOX11 0DF
Phone44-18-6581-8808
Websitehttp://www.barinthusbio.com
Company Executives
- Name
- Position
- Salary
- William J. Enright
- Chief Executive Officer and Director
- 1.81M
- Geoffrey Lynn, M.D.,PhD
- Chief Scientific Officer
- --
- Gemma Brown
- Chief Financial Officer and Principal Accounting Officer
- --
- Graham Griffiths
- Chief Operating Officer
- 731.06K
- Robin Wright
- Chairman of the Board
- 117.13K
- Dr. Alex Hammacher
- Director
- 71.11K
- Karen A. Dawes, M.A.
- Independent Director
- 81.69K
- Dr. Pierre A. Morgon, Pharm.D.
- Independent Director
- 85.42K
- Dr. Anne M. Phillips, M.D.
- Independent Director
- 81.06K
- Dr. Joseph C.F. Scheeren, B.S.,M.Sc.,Pharm.D.
- Independent Director
- 79.82K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
